Live Research Database
Psoriasis
Hub: Portland, OR
Connecting patients in Portland with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Oregon
Available Psoriasis Opportunities
8 RecruitingNCT06857942(Verify)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT07290569(Verify)
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
RECRUITING
Psoriasis
NCT02418442(Verify)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
Psoriasis
NCT07449702(Verify)
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
RECRUITING
Psoriasis
NCT06641089(Verify)
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
RECRUITING
Psoriasis
NCT07013201(Verify)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
RECRUITING
Psoriasis
NCT06454188(Verify)
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Portland through safe, transparent, and patient-first clinical trials."
Research Hubs in Portland
Explore other local breakthroughs
Psoriasis Hubs in OR
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT